388 related articles for article (PubMed ID: 28356021)
21. Synthesis of Hybrids of Dihydropyrimidine and Pyridazinone as potential Anti-Breast Cancer Agents.
Akhtar W; Verma G; Khan MF; Shaquiquzzaman M; Rana A; Anwer T; Akhter M; Alam MM
Mini Rev Med Chem; 2018; 18(4):369-379. PubMed ID: 28486908
[TBL] [Abstract][Full Text] [Related]
22. Methylene-bearing sulfur-containing cyanopyrimidine derivatives for treatment of cancer: Part-II.
Akhtar W; Nainwal LM; Kaushik SK; Akhtar M; Shaquiquzzaman M; Almalki F; Saifullah K; Marella A; Alam MM
Arch Pharm (Weinheim); 2020 May; 353(5):e1900333. PubMed ID: 32115728
[TBL] [Abstract][Full Text] [Related]
23. Dihydropyrazole Derivatives Containing Benzo Oxygen Heterocycle and Sulfonamide Moieties Selectively and Potently Inhibit COX-2: Design, Synthesis, and Anti-Colon Cancer Activity Evaluation.
Yan XQ; Wang ZC; Zhang B; Qi PF; Li GG; Zhu HL
Molecules; 2019 Apr; 24(9):. PubMed ID: 31052167
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors.
Coşkun GP; Djikic T; Hayal TB; Türkel N; Yelekçi K; Şahin F; Küçükgüzel ŞG
Molecules; 2018 Aug; 23(8):. PubMed ID: 30082676
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Biological Evaluation of 1,3,5-Trisubstituted 2-Pyrazolines as Novel Cyclooxygenase-2 Inhibitors with Antiproliferative Activity.
Vahedpour T; Kaur J; Hemmati S; Hamzeh-Mivehroud M; Alizadeh AA; Wuest F; Dastmalchi S
Chem Biodivers; 2021 Mar; 18(3):e2000832. PubMed ID: 33620122
[TBL] [Abstract][Full Text] [Related]
26. Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
Huang RZ; Liang GB; Huang XC; Zhang B; Zhou MM; Liao ZX; Wang HS
Eur J Med Chem; 2017 Sep; 138():979-992. PubMed ID: 28756264
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents.
Saeed S; Rashid N; Jones PG; Ali M; Hussain R
Eur J Med Chem; 2010 Apr; 45(4):1323-31. PubMed ID: 20056520
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents.
Firke SD; Bari SB
Bioorg Med Chem; 2015 Sep; 23(17):5273-81. PubMed ID: 26277757
[TBL] [Abstract][Full Text] [Related]
29. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
[TBL] [Abstract][Full Text] [Related]
30. Biological evaluation of some new N-(2,6-dimethoxypyrimidinyl) thioureido benzenesulfonamide derivatives as potential antimicrobial and anticancer agents.
Ghorab MM; Alsaid MS; El-Gaby MSA; Safwat NA; Elaasser MM; Soliman AM
Eur J Med Chem; 2016 Nov; 124():299-310. PubMed ID: 27597407
[TBL] [Abstract][Full Text] [Related]
31. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
Parmar DR; Soni JY; Guduru R; Rayani RH; Kusurkar RV; Vala AG; Talukdar SN; Eissa IH; Metwaly AM; Khalil A; Zunjar V; Battula S
Bioorg Chem; 2021 Oct; 115():105206. PubMed ID: 34339975
[TBL] [Abstract][Full Text] [Related]
32. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents.
Li Z; Wang ZC; Li X; Abbas M; Wu SY; Ren SZ; Liu QX; Liu Y; Chen PW; Duan YT; Lv PC; Zhu HL
Eur J Med Chem; 2019 May; 169():168-184. PubMed ID: 30877972
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and anticancer activity of thiourea derivatives bearing a benzodioxole moiety with EGFR inhibitory activity, apoptosis assay and molecular docking study.
Abbas SY; Al-Harbi RAK; Sh El-Sharief MAM
Eur J Med Chem; 2020 Jul; 198():112363. PubMed ID: 32361329
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents.
Yao RS; Lu XQ; Guan QX; Zheng L; Lu X; Ruan BF
Eur J Med Chem; 2013 Apr; 62():222-31. PubMed ID: 23353741
[TBL] [Abstract][Full Text] [Related]
36. Discovery of novel aminophosphonate derivatives containing pyrazole moiety as potential selective COX-2 inhibitors.
Zhang B; Hu XT; Zhou KM; Yang YS; Zhu HL
Bioorg Chem; 2020 Sep; 102():104096. PubMed ID: 32707279
[TBL] [Abstract][Full Text] [Related]
37. Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; El-Gazzar MGM
Bioorg Med Chem Lett; 2018 May; 28(9):1464-1470. PubMed ID: 29628325
[TBL] [Abstract][Full Text] [Related]
38. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes.
El-Miligy MMM; Al-Kubeisi AK; El-Zemity SR; Nassra RA; Abu-Serie MM; Hazzaa AA
Bioorg Chem; 2021 Oct; 115():105171. PubMed ID: 34303896
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
Huang X; Huang R; Liao Z; Pan Y; Gou S; Wang H
Eur J Med Chem; 2016 Jan; 108():381-391. PubMed ID: 26706349
[TBL] [Abstract][Full Text] [Related]
40. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity.
Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM
Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]